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Abstract 
Craniopharyngiomas are rare, highly 
complex tumors with bimodal incidence in 
the pediatric and adult age groups. In our 
opinion, depending on the means possible, 
total microscopic ablation offers the best 
chance of healing, or at least prolongs the 
time interval of recurrences. 
Objective: The purpose of this paper is 
to add our surgical experience to in the last 
11 years, in the context of the large debate 
from literature regarding the best 
therapeutically option concerning 
craniopharyngioma treatments. 
Materials and Methods: We performed 
a retrospective analysis of 42 consecutive 
patients with craniopharyngioma who 
underwent surgical resection by one 
surgeon at the Neurosurgical Department 
of Cluj-Napoca County Emergency 
Hospital between January 2002 and 
December 2012. We perform a systematic 
review of the published review on goals 
and techniques associated with selected 
surgical strategies for the treatment of 
CPH. 
Results: During this period a total of 42 
patients with craniopharyngioma were 
treated in our institution by a single 
neurosurgeon, representing 12% from all 
cases of sellar and parasellar tumors 
respectively operated in last 11 years. 
There is a significant male 
preponderance. Nine patients were less 
than 18 years of age at admission. The 
patient age distribution showed a peak 
incidence between 10 and 15 years and 
another between 45 and 50 years. 
Considering the pediatric and adult 
populations together, the most common 
presenting symptom was visual 
disturbances with 60% of patients 
presenting in this manner, followed by 
severe headache in more than 50% of 
cases. Obstructive hydrocephalus occurred 
in 31% of cases. Calcifications were seen 
in 45% of cases, more frequently in 
children. 
All our cases underwent surgery by 
transcranial approach; extended fronto-
temporal, as the first choice, in 57% of 
cases. Gross total removal was achieved in 
over half of cases and near total resection 
was achieved in 40% of cases. The most 
frequent postoperative complications: 
diabetes insipidus and syndrome of 
inappropriate antidiuretic hormone 
secretion. No visual impairment was 
observed after surgery in the patients with 
  
 
38        Pintea et al          Craniopharyngioma: How to deal with? 
 
 
 
normal visions at presentation. Only 3 of 
cases primarily operated by us recurred, in 
an interval of one to five years. The 
mortality rate in our cases treated by 
transcranial surgery was 2% in primary 
cases and 7% in cases of tumor recurrence. 
Conclusions: Radical surgery offers the 
best chance for cure. Radical surgery is 
also associated with a higher risk of 
postoperative morbidity, being the reason 
for why many neurosurgeons recommend 
a subtotal resection followed by 
radiotherapy. In our opinion radical 
surgery is possible in large majority of the 
cases, fronto-temporal approach offering 
the most appropriate way to reach this 
objective. Every case must be judged with 
maximal attention based on preoperative 
neuroimagistic data but decisively, on 
intraoperative findings. 
Introduction 
Craniopharyngiomas are rare, highly 
complex tumors with bimodal incidence in 
the pediatric and adult age groups. These 
dysontogenic tumors are benign histology 
but with malignant behavior by infiltrative 
tendency into critical parasellar 
neurovascular structures, and by tendency 
to recurrence despite the impression that 
they were completed resected. [26] 
Craniopharyngioma, described by Cushing 
as “one of the most baffling problems 
which confront the neurosurgeon”, 
account for less than 3% of all intracranial 
tumors at adults and 6- 7% from all brain 
tumors in children. [24, 44] 
In recent years there is a large 
difference of opinion in regards to 
multimodal treatment of CPH, from 
intracranial approaches with total tumor 
resection or subtotal resection followed by 
radiotherapy, to an endoscopic approach, 
or a combination of both. In regards to 
residual tumors of small dimensions, the 
recent trend is to use of 3-dimensional 
conformal radiation treatment (3D CRT), 
stereotactic radiosurgery (SRS), stereotactic 
radiotherapy (SRT), and intensity-
modulated radiation therapy (IMRT). [42] 
In our opinion, depending on the means 
possible, total microscopic ablation offers 
the best chance of healing, or at least 
prolongs the time interval of recurrences. 
Objective 
 The purpose of this paper is to add our 
surgical experience to in the last 11 years, 
in the context of the large debate from 
literature regarding the best therapeutically 
option concerning craniopharyngioma 
treatments. 
 Materials and methods 
We performed a retrospective analysis 
of 42 consecutive patients with 
craniopharyngioma who underwent 
surgical resection by one surgeon at the 
Neurosurgical Department of Cluj-Napoca 
County Emergency Hospital between 
January 2002 and December 2012. We 
discussed the tumor’s characteristics that 
could influence the treatment decision and 
the choice of the most reliable approach. 
The postoperative follow-up was done at 
one and three month when first control 
  
 
Romanian Neurosurgery (2014) XXI 1: 37 - 49         39 
 
 
 
MRI is also performed. All the patients 
were followed up every 3 to 6 months in 
the first year after discharge from the 
hospital, and mail correspondence and/or 
telephone interviews were used after one 
year. We perform a systematic review of 
the published review on goals and 
techniques associated with selected surgical 
strategies for the treatment of CPH. 
Results 
From January 2000 to December 2012 a 
total of 42 patients with 
craniopharyngioma were treated in our 
institution by a single neurosurgeon, 
representing 12% from all cases of sellar 
and parasellar tumors respectively 1, 39% 
of all tumors (3006 cases) operated in this 
period. At pediatric age we found that 
approximately half of all suprasellar 
tumors are craniopharyngioma, compared 
with only about 10% in adults. 
 
Figure 1 A 
Preoperative sagittal contrast- enhanced T1 
weighted MRI showed a case of suprasellar solid 
craniopharyngioma extending from the infudibular 
area into the third ventricle 
 
Figure 1 B 
Postoperative T1 weighted MRI shows a total 
removal of the craniopharyngioma by fronto-
temporal approach 
 
  
 
  
Figure 2 A, B, C, D 
Preoperative axial (a), coronal (b) and sagittal (c) 
T1-weighted MRI showed a giant suprasellar 
craniopharyngioma with a cystic portion extending 
into the third ventricle and left lateral ventricle. 
Three weeks after operation post-contrast CT scan 
(d) showed a small calcified nodule residual 
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Figure 3 A, B 
Preoperative sagittal and coronal contrast-enhanced 
T1 weighted MRI demonstrating a suprasellar 
tumor with inhomogeneously enhancing solid 
tumor part 
 
  
Figure 3 C, D 
CT scan at 48 hours after modified right 
frontotemporal approach. A gross total tumor 
resection was achieved. 
  
 
 
Figure 4 A, B, C 
Preoperative coronal, axial and sagittal contrast-
enhanced T1 weighted MRI demonstrating a giant 
suprasellar tumor with a large cyst extending in the 
third ventricle and left lateral ventricle with areas of 
calcifications and the presence of the Ommaya 
reservoir. 
  
 
 
Figure 4 D, E, F 
CT scan at 48 hours after modified right 
bifrontotemporal approach. A gross total tumor 
resection was achieved. 
 
There is a significant male 
preponderance. Of the 42 patients, 24 were 
males and 18 were females, with a mean 
age of 27 years (range 4 to 70 years). Nine 
patients (22%) were less than 18 years of 
age at admission. The patient age 
distribution showed a peak incidence 
between 10 and 15 years. Another peak 
was found between 45 and 50 years. In 
17% of the cases, the histological 
characteristics of the craniopharyngiomas 
were of the papillary type and in 83% of 
the adamantinomatous type. 
Overall the clinical disorders were 
nonspecific and have included visual 
deficits, endocrine and behavioral 
impairments. Considering the pediatric 
and adult populations together, the most 
common presenting symptom was visual 
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disturbances (visual field defects, decreased 
visual acuity or visual deterioration), with 
60% of patients presenting in this manner, 
followed immediately by severe headache 
in more than 50% of cases. Neurological 
symptoms were relatively uncommon. 
Symptoms related to hydrocephalus, 
headaches, nausea and vomiting occurred 
more frequently in children than in adults. 
In children, the most common 
presentation was that of growth failure. In 
adults, hypogonadism was the most 
common presentation followed by visual 
deficits and symptoms of raised 
intracranial pressure. Other less common 
features include seizures, motor disorders, 
emotional lability, hallucinations, and 
precocious puberty, polyuria/polydipsia 
and weight disorders. 
Preoperative work-up tests included 
computerized tomography (CT) scanning 
and magnetic resonance imaging (MRI). 
Obstructive hydrocephalus occurred in 13 
(31%) of cases. Calcifications were seen in 
19 (45%) of cases, more frequently in 
childhood populations. Predominantly 
cystic mass was detected in 24 % of cases, 
partially cystic tumor and solid tumor in 
the rest of 76% cases. 
All our cases underwent surgery by 
transcranial approach, extended fronto-
temporal, as the first choice, in 24 of cases 
(57%); we have choose transcallosal 
interemispheric route or subfrontal 
interemispheric route  by bifrontal 
approach in 8 of cases (19%); 
bifrontopterional craniotomy and 
combined routes were reserved for 
multidirectional approach of giant tumors, 
in 24% of cases. Four patients (10%) had 
undergone previous surgery in other 
centers.  In one case we have inserted an 
Ommaya reservoir and we operated the 
case after 11 years, because of refuse of 
parents to accept radical intervention. In 
this particular case we obtain a gross total 
removal in a single surgical stage, despite 
the huge dimensions of the tumor. Our 
intention was gross total resection in all 
cases and we succeed this in over half of 
the patients. Near total resection, meaning 
that a small remnant of tumor capsule or 
calcified portion of the tumor was left in 
place because of was a firm adherence to 
hypothalamus, major calcifications, very 
thin capsule and adherence to perforating 
vessels or greater vessels from the polygon 
of Willis, was achieved in 40% of our 
cases. Of all the survival patients the most 
frequent postoperative complications was 
diabetes insipidus and syndrome of 
inappropriate antidiuretic hormone 
secretion, despite de fact that the 
preservation of pituitary stalk is one of our 
goals during the surgery. One of the most 
difficult problems in the postoperative 
period was the treatment of 
hydroelectrolithic disturbances 
encountered especially in very large 
tumors. Postoperative endocrine 
abnormalities were treated by 
corticosteroids and thyroid hormone 
replacement. Treatment of long-term 
hormone deficits varies based on the type 
of deficiency and it’s made by 
endocrinologist. Visual acuity and visual 
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field defects were found in 25 of patients 
before surgery; in two of them the 
symptoms was transient aggravated after 
the operation, while in 12 (48%) patients 
there was an improvement of vision at 1 
month after surgery. No visual impairment 
was observed after surgery in the patients 
with normal visions at presentation. Two 
patients had oculomotor paralysis after the 
operation, one of them recovered 
significantly. Among the long-term 
complications found in our series, we 
mention: diabetes insipidus with impaired 
sense of thirst, hypothalamic disturbances 
with hyperphagia and obesity, the 
deterioration of cognitive function and 
excessive daytime sleepiness. Only three of 
cases primarily operated by us recurred, in 
an interval of one to five years. Treatment 
of recurrences is difficult and perioperative 
morbidity is significantly increased 
compared to treatment of primary tumor. 
The operative mortality rate in our cases 
treated by transcranial surgery was 2% in 
primary cases and 7% in cases of tumor 
recurrence. 
Discussion  
There is no agreement in regards to the 
optimal management of 
craniopharyngiomas; there are proponents 
to aggressive total surgical resection, when 
others are in favor of partial resection 
followed by radiotherapy. The natural 
history of these lesions is not fully known 
yet. Surgical resection is the mainstay of 
definitive treatment and it is the most 
effective in order to prevent recurrences. 
Skull base approaches described for the 
excision of craniopharyngiomas can be 
simplified into: anterior midline 
(subfrontal, transsphenoidal); anterolateral 
(pterional, orbitozygomatic); and 
intraventricular (transcallosal–transven-
tricu-lar, transcortical–transventricular, 
translamina terminalis) approaches. [2, 10, 
21] Since such a variety of surgical 
approaches exists in the management of 
these tumors, the experience of the surgical 
team is extremly important. 
From a topographical standpoint, there 
are two types of craniopharyngiomas: 
intrasellar, localized in the anterior 
pituitary gland with extension sometimes 
even before the optic chiasma, and 
infundibulotuberian, whose anterior 
extension to the chiasma is rare; also 
describing CPH which develop especially 
on the floor of the third ventricle. [26, 44] 
Histologically, there are two types of 
CPH: classic adamantin type, heterogenic, 
in the most part solid, which is most likely 
found in children; and a papillary type 
(scuamos papillary and 
adamantinomatous). Scuamous papillary is 
predominantly cystic, found almost 
exclusively in adults, and seems to have a 
better prognosis than the adamantin. 
Criteria for choosing a surgical 
approach depends on the origin of the 
tumor with relation to the diaphragma 
sellae, enlargement of the sella turcica, the 
extension of intratumoral cysts, shape and 
size of the CPH, as well as extension under 
the pia mater. 
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Intraoperative MRIs have proven useful 
in detecting residual tumor and in 
obtaining a more radical resection. 
Although, they can produce false images 
due to blood which may accumulate 
intraoperatively, making it difficult to 
differentiate between intracapsular 
hemorrhage and residual tumor. [40]. 
In Hoffman's 1998 opinion [21], which 
advocated total excision whenever possible 
and achieve gross total resection in the 
majority of cases in their series of 
suprasellar tumors, transcranial surgical 
approaches indicated for CPH resection 
can be classified by: 
1. Pterional transsylvian approach: small 
suprasellar tumors, as well as large 
intrasellar tumors with suprasellar 
extension; translaminaterminalis pterional 
approach for intraventricular tumors. 
2. Combined pterional-transcallosal 
anterior-transventricular approach: large 
suprasellar tumors with 3rd ventricle 
extension. 
3. Transcallosal-transventricular 
approach: tumors exclusively 
intraventricular 
Our experience is in agreement with the 
report of Yasargil et al. [56] They point out 
the crucial role of complete tumor removal 
rather than risking repeated surgical 
procedures and/or radiation therapy for 
tumor recurrences. According to them [56 
]the pterional (aka frontotemporal) 
approach is the workhorse for the surgical 
resection of craniopharyngiomas involving 
primarily the suprasellar cistern.[56] This 
exposure is suitable for removing 
craniopharyngiomas involving the 
intrasellar, suprasellar, prechiasmatic, and 
retrochiasmatic regions. This is also the 
preferred method in patients with a 
prefixed chiasm, because the tumor can be 
resected beneath the chiasm. A 
disadvantage of the pterional approach is 
the limited view of the contralateral 
opticocarotid triangle and the contralateral 
retrocarotid space. [10] 
 Baskin DS et al studied on 74 patients 
retrospectively with craniopharyngiomas 
treated during a 15 year period. They 
reviewed the radiological appearances, 
presenting symptoms before and after 
treatment initiation, surgical approaches 
and the degree of tumoral resection. Based 
on this data they concluded that radical 
subtotal removal followed by radiotherapy 
is an acceptable treatment for 
craniopharyngioma. [3] 
Broggi believes that the standard 
pterional approach is still indicated for 
middle fossa extension of tumors even 
though the use of the pterional approach 
decreased in the last decade in favor of less 
invasive approaches. In case of cystic 
craniopharyngiomas 
cystoventriculostomy/cystocysternostomy 
may be used. [5] 
In Chakrabarti et al 2005’s opinion, 
[9,11] the scope of surgical intervention 
consists of resecting as much as possible of 
the tumor from the first intervention, any 
residual tumor being controlled by 
radiosurgery, considering that it is easier to 
accept a subtotal resection than a severe 
complication. N.Gupta et al suggests that 
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in case of pediatric craniopharyngiomas 
gross total removal is associated with 
increased rates of endocrinopathies 
compared with subtotal removal and 
radiotherapy. [1, 19] 
On the contrary, Fahlbush, [14] in a 
study of 168 consecutive patients, treated 
between January 1983 and April 1997, 
concludes that total tumor removal with 
condition of avoiding intraoperative 
hazardous gestures offers favorable results 
immediately postoperative and a longer 
time frame until recurrence. Total tumor 
resection was obtained in 50% of cases 
with transcranial approaches and in 85% 
by transsphenoidal approaches. The most 
frequent surgical approach used in his 
study was a pterional approach in 39% of 
cases, followed by transsphenoidal in 23% 
of cases, bifrontal interemispherical 
approach being reserved for large 
retrochiasmatic craniopharyngiomas. So 
authors recommended the pterional 
transsylvian approach in all situations 
where the optic chiasm is postfixed but, if 
required, the these approach also allows 
access to the inferior anterior third 
ventricle through the lamina terminalis. 
In a large study of 284 patients with 
CPH which were treated exclusively by 
transcranial approaches by Shi Xang et al, 
[48] the pterional approach was chosen in 
191 cases, due to the inferior or superior 
location of the tumor in relation to the 
floor of third ventricle. They consider that 
preserving the integrity of the 
hypothalamic structures, the perforating 
artery of the the pituitary gland being 
possible by choosing an optimal approach 
based on the relation of the tumor to the 
floor of the 3rd ventricle. 
In the period from 2001-2011, 66 
patients with giant craniopharyngiomas 
were operated on at the International 
Neuroscience Institute in Hannover, via 
the frontolateral approach. The resection 
was confirmed using intraoperative MRI or 
early postoperative MRI in some cases. 
The authors conclude that frontolateral 
approach allows safe and radical removal 
even of giant or extensive 
craniopharyngiomas; hidden parts can be 
examined with an angled endoscope. [18] 
 On the contrary, J. C. Fernandez-
Miranda, E. W. Wang et al [30] studied on 
55 patients retrospectively with 
craniopharyngiomas admitted at 
Neurosurgery Department of Pittsburgh 
Medical Center (42 with primary 
craniopharyngiomas and 13 with 
recurrent). They present that total or near 
total (>95% of tumor) resection was 
achieved in 66.6% of cases by endoscopic 
endonasal surgery. Recurrence occurred in 
18 patients (32.7%), and they were treated 
with repeat surgery or radiosurgery. Based 
on this data they concluded that this 
approach provides good results comparable 
with traditional approaches. [30] 
In case of pediatric craniophryngiomas 
opinions varies depending on patients age. 
At Center for Endoscopic Skull Base 
Surgery, Bologna, Italy, endoscopic 
endonasal surgery has become the 
approach of choice for midline pediatric 
craniopharyngiomas, in patients older than 
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13 years with gross total removal in 
majority of cases and without signs of 
hypothalamic compromising. [16] 
Michael L.Levy, in his study on 54 cases 
of pediatric craniopharyngiomas concludes 
that the best approach is the one who 
provides optimum exposure to maximize 
the chances for total resection, even 
combined surgical approaches. 
Besides classic frontopterional 
approaches, neuroendoscopic procedures 
are becoming more popular in the 
neurosurgical treatment of 
craniopharyngioma. Typically, 
transsphenoidal approaches were reserved 
for sellar tumors and for those with 
suprasellar extension if the sella turcica 
appears enlarged, but even in “hourglass” 
tumors, more so if suprasellar extension is 
round and symmetrical. [11, 14] Presently, 
the indications of this approach have 
expanded including suprasellar tumors 
with normal dimensions, introducing 
another two types of transsphenoidal 
approaches: transsellar-transdiaphragmatic 
and presellar-tubercular. [27, 29]  In 1990, 
Yasargil used this approach in 9.7% of 144 
cases studied, Van Effentere in just 8%, 
and Maira in his 2004 study declares 63% 
of cases confirmed a complete CPH 
resection by a transsphenoidal approach. 
[35, 53, 56] In Fahlbush opinion [14] 
transsphenoidal surgery has the great 
advantage of not disturbing hypothalamic 
function. 
In a study conducted by Shozo Y.et al 
[49]  90 patients with craniopharyngiomas 
were evaluated prospectively at 
Department of the Hypothalamic and 
Pituitary Surgery Tokyo and  treated by 
transsphenoidal surgery or extended 
transsphenoidal surgery; total removal was 
achieved in 77,8% of cases, including 
supradiaphragmatic type, with a good 
outcome. According to the authors dural 
fascia graft is a very effective technique to 
prevent CSF leaks in this cases. [49] 
Regarding the management of 
intradural bleeding during the extended 
transsphenoidal surgery Cappabianca’s 
opinion is that the thrombin- gelatin 
topical haemostatic could be a valuable 
tool when other strategies to stops 
bleeding, at the level of superior 
intercavernous sinus are ineffective, even 
the ones with high- flow. [7] 
Craniopharyngiomas have a tendency to 
recur even after apparent total resection 
and radiation therapy. [54] Literature 
reports between 0 to 50%. Recurrence 
rates of craniopharyngiomas even after 
aggressive surgical resection reported by 
Yasargil in his study was of 7%; [56] 
Backland in his 1994 study regarding 
recurrence rates in a large time interval 
came to the conclusion that it can reach 
50%. [2] There are also some cases 
reported of ectopic recurrences, at a 
distance of the tumor location as well as 
the surgical path. [34]. Treatment options 
for recurrent craniopharyngioma include 
repeat surgery, radiotherapy and intracystic 
bleomycin therapy. 
The most consistently reported feature 
predictive for recurrence of 
craniopharyngioma is the extent of 
  
 
46        Pintea et al          Craniopharyngioma: How to deal with? 
 
 
 
resection at initial surgery as well the 
tumor diameter greater than 4 cm to 5 cm; 
extrasellar extension; extension into the 
third ventricle; the degree of tumor 
adhesion; hydrocephalus and tumors with 
greater than 10% calcification.[ 12, 13, 19, 
24, 48, 56]. Matson and Crigler, in 1969, 
postulated that “total excision must be 
attempted at the first operation” [37] 
Radiation therapy is a reference point in 
the therapeutic management of 
craniopharyngioma. Today less radical 
surgery in combination with radiation 
therapy is favored achieving a progression-
free survival between 70 and 90%. [14, 52] 
The major advantage of proton therapy 
is the high degree of dose conformity to 
the target. Beltran et al, [4] retrospectively 
evaluated proton treatment plans with 
IMRT plan. He concluded that compared 
with photon IMRT proton therapy has the 
potential to significantly reduce whole 
brain and body irradiation. Retrospective 
evaluation of outcomes in 15 patients with 
craniopharyngioma treated with a mix of 
photon and protons by Fitzek et al. reveals 
that the tumor control rates at 5 and 10 
years were 93 and 85%, respectively. [15] 
Stereotactic instillations of radioisotopes 
represent in the last period an alternative 
therapeutic option, for monocystic 
craniopharyngioma recurrences. Though, 
this treatment method is restricted to cystic 
childhood craniopharyngioma and should 
be considered only for postoperative 
recurrences and after percutaneous 
irradiation. [25, 50] 
In opinion of Voges and Hasegawa [20, 
55], response rates and cyst controls can be 
achieved in more than 80% case of cystic 
craniopharyngiomas after intracavitary 
application of different isotopes such as 
Rhenium186, Yttrium90, or Phosporus32.  
Researchers are studying several 
theories about the radiosurgery and 
conclude that tumor control is inferior to 
fractionated treatments and might carry 
the risk for optic neuropathies unless only 
smaller lesions are treated away from the 
optic apparatus. [39, 51]  
Bleomycin, an antineoplastic antibiotic 
that interferes with DNA production, was 
first introduced in cystic CPH treatment 
by Takahasi in 1985. Intracystic 
administration by stereotactic techniques 
determines a decrease in intracystic fluid 
secretion and favors tumor cell 
degeneration. In recent years the routine 
use of Bleomycin has been decreased due 
to a series of complications reported such 
as occlusive vasculopathy, pulmonary 
fibrosis, bilateral hypoacusis, hypersomnia, 
thermal disfunction. [45,46]. Recent 
reports on the effect and tolerability of 
intracystic instillation of interferon α are 
promising [23] 
According to Cavalhero et al in their 
1996 study, the implantation of an 
intracystic catheter with a subcutaneous 
reservoir and instillation of sclerosing 
substances represent a useful therapeutic 
method for cystic recurrent tumors whose 
anatomical configuration and localization 
make them difficult to resect. [8, 47]  
  
 
Romanian Neurosurgery (2014) XXI 1: 37 - 49         47 
 
 
 
In a study published in 2004, Bricolo 
and collaborators present therapeutic 
efficiency of a multimodality stereotactic 
approach to regrowing/recurrent cystic 
craniopharyngiomas: neuroendoscopy, 
intracavitary bleomycin and gamma knife 
(GK) radiosurgery. [32, 39] Ohata K. et al 
[41] conclude that “the use of radiosurgery 
for craniopharyngioma is still a matter of 
discussion”. 
Conclusions 
Radical surgery offers the best chance 
for cure. Radical surgery is also associated 
with a higher risk of postoperative 
morbidity, being the reason for why many 
neurosurgeons recommend a subtotal 
resection followed by radiotherapy. In our 
opinion radical surgery is possible in large 
majority of the cases, fronto-temporal 
approach offering the most appropriate 
way to reach this objective. Every case 
must be judged with maximal attention 
based on preoperative neuroimagistic data 
but decisively, on intraoperative findings. 
Radical surgery could be an objective, but 
this must not be an objective with every 
cost, because the cost could be too high. 
Despite advances in neuroimaging, 
microsurgical techniques and hormone 
replacement multimodal treatment, the 
overall prognosis remains reserved on long 
term follow-up. 
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